AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

4,023
Loading...
Loading...
Upcoming Earnings: Q3 '25
Reports: Nov 07,
Pre-Market

Estimated EPS

$0.16

Estimated Rev

$768.1M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
$0.16
--
--
N/A
Q2 '25
$0.17
$0.25
42.86%
BEAT
Q1 '25
$0.15
$0.21
43.18%
BEAT
Q4 '24
$0.15
$0.12
-21.31%
MISSED
Q3 '24
$0.13
$0.16
19.04%
BEAT

Latest AMRX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.